Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
20.57 USD | -6.12% | +3.73% | -9.10% |
Evolution of the average Target Price on Aerovate Therapeutics, Inc.
Price target over the last 5 years
History of analyst recommendation changes
Analysts' Consensus
Consensus detail
Consensus revision (last 18 months)
Analysts covering Aerovate Therapeutics, Inc.
Wedbush | |
Guggenheim | |
BTIG | |
Jefferies & Co. | |
Cowen | |
Evercore ISI |
EPS Revisions
- Stock Market
- Equities
- AVTE Stock
- Consensus Aerovate Therapeutics, Inc.